FDA supports open data to improve patient safety

The U.S. Food and Drug Administration signed a letter of support May 30 for openly sharing data through efforts such as the Patient Safety Movement Foundation’s Open Data Pledge, according to an announcement made June 27.

Advertisement

The FDA says open data engages patients in developing and evaluating medical devices, allows for the identification and prevention of adverse events and sheds light on the benefits and risks of healthcare technology. 

 Leaders in healthcare technology commit to openly sharing data when they sign the Patient Safety Movement’s Open Data Pledge. Algorithms based on the data help reduce preventable patient harm and deaths.

More articles on clinical leadership and infection control:
Viewpoint: The US must eliminate non-medical vaccine exemptions
Senators introduce bill to address high maternal and infant mortality in US: 4 things to know
CDC panel recommends HPV vaccine for some adults

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.